The key findings of our pilot study are that the TSPO ligand [11C]PBR28 showed a transient increased signal, only within the infarcted area, in the subacute phase of stroke and that this evidence of circumscribed glial activation resolved within 90 days. Here, TSPO is linked to stroke disorder.